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The Journal of Pediatric Orthopaedics promotes communication of information on pediatric 
orthopedic problems and advances in patient care. We urge authors to comply with ethical 
principles as outlined in the Declaration of Helsinki (see J Pediatr Orthop editorial 
1998;18:7012). 
ETHICAL/LEGAL CONSIDERATIONS 
A submitted manuscript must be an original contribution not previously published (except 
as an abstract or a preliminary report), must not be under consideration for publication 
elsewhere, and, if accepted, must not be published elsewhere in similar form, in any 
language, without the consent of Lippincott Williams & Wilkins. Each person listed as an 
author is expected to have participated in the study to a significant extent. Although the 
editors and referees make every effort to ensure the validity of published manuscripts, the 
final responsibility rests with the authors, not with the Journal, its editors, or the publisher. 
All manuscripts must be submitted on-line through the Journal's Web site at 
http://jpo.edmgr.com/. See submission instructions under "On-line manuscript 
submission." 
Patient Anonymity and Informed Consent 
It is the author's responsibility to ensure that a patient's anonymity be carefully protected 
and to verify that any experimental investigation with human subjects reported in the 
manuscript was performed with informed consent and following all the guidelines for 
experimental investigation with human subjects required by the institution(s) with which 
all the authors are affiliated. Authors should remove patients' names and other identifying 
information from figures. If any identifying details appear in text, tables, and/or figures, 
the author must provide proof of informed consent obtained from the patient (i.e., a 
signed permissions form). Photographs with bars placed over eyes of patients should NOT 
be used in publication. If they are used, permission from the patient is required. 
Copyright 
All authors must sign a copy of the Journal's "Authorship Responsibility, Financial 
Disclosure, and Copyright Transfer" form and submit it at the time of manuscript 
submission to Julie Chase at (fax) 215-827-5586. 
Open access 
LWW’s hybrid open access option is offered to authors whose articles have been accepted 
for publication. With this choice, articles are made freely available online immediately upon 
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publication. Authors may take advantage of the open access option at the point of 
acceptance to ensure that this choice has no influence on the peer review and acceptance 
process. These articles are subject to the journal’s standard peer-review process and will 
be accepted or rejected based on their own merit.  
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual 
unrestricted online access to their published article to readers globally, immediately upon 
publication. The article processing charge for Journal of Pediatric Orthopaedics is $2,000. 
The article processing charge for authors funded by the Research Councils UK (RCUK) is 
$2,580. The publication fee is charged on acceptance of the article and should be paid 
within 30 days by credit card by the author, funding agency or institution. Payment must 
be received in full for the article to be published open access. Any additional standard 
publication charges, such as for color images, will also apply.  
• Authors retain copyright 
Authors retain their copyright for all articles they opt to publish open access. 
Authors grant LWW a license to publish the article and identify itself as the original 
publisher.  
• Creative Commons license 
Articles opting for open access will be freely available to read, download and share 
from the time of publication. Articles are published under the terms of the Creative 
Commons License Attribution-NonCommerical No Derivative 3.0 which allows 
readers to disseminate and reuse the article, as well as share and reuse of the 
scientific material. It does not permit commercial exploitation or the creation of 
derivative works without specific permission. To view a copy of this license visit: 
http://creativecommons.org/licenses/by-nc-nd/3.0.  
• Compliance with NIH, RCUK, Wellcome Trust and other research funding 
agency accessibility requirements 
A number of research funding agencies now require or request authors to submit 
the post-print (the article after peer review and acceptance but not the final 
published article) to a repository that is accessible online by all without charge. As 
a service to our authors, LWW identifies to the National Library of Medicine (NLM) 
articles that require deposit and transmits the post-print of an article based on 
research funded in whole or in part by the National Institutes of Health, Howard 
Hughes Medical Institute, or other funding agencies to PubMed Central. The 
revised Copyright Transfer Agreement provides the mechanism. LWW ensures that 
authors can fully comply with the public access requirements of major funding 
bodies worldwide. Additionally, all authors who choose the open access option will 
have their final published article deposited into PubMed Central.  
 
RCUK and Wellcome funded authors can choose to publish their paper as open 
access with the payment of an article process charge (gold route), or opt for their 
accepted manuscript to be deposited (green route) into PMC with an embargo.  
 
With both the gold and green open access options, the author will continue to sign 
the Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to 
ensure that the author is fully compliant with the requirements. After signature of 
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the CTA, the author will then sign a License to Publish where they will then own 
the copyright. Those authors who wish to publish their article via the gold route 
will be able to publish under the terms of the Attribution 3.0 (CCBY) License. To 
view of a copy of this license visit: http://creativecommons.org/licenses/by/2.0/. 
Those authors who wish to publish their article via the green route will be able to 
publish under the rights of the Attribution Non-commercial 3.0 (CCBY NC) license 
(http://creativecommons.org/licenses/by-nc/2.0/).  
 
It is the responsibility of the author to inform the Editorial Office and/or LWW that 
they have RCUK funding. LWW will not be held responsible for retroactive deposits 
to PMC if the author has not completed the proper forms.  
FAQ for open access 
http://links.lww.com/LWW-ES/A48  
Conflicts of interest  
For the timespan covering the work being presented (study planning, conduct, analysis, 
and dissemination to date), authors are required to disclose all possible conflicts of interest 
in the manuscript, including financial, consultant, institutional and other relationships that 
might lead to bias or a conflict of interest. If there is no conflict of interest, this should also 
be explicitly stated as none declared. All sources of funding should be acknowledged in the 
manuscript. All relevant conflicts of interest and sources of funding should be included on 
the title page of the manuscript with the heading “Conflicts of Interest and Source of 
Funding:”. For example:  
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B 
is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s 
bureau for Organization X – the CME organizers for Company A. For the remaining authors 
none were declared.  
In addition, each author must complete and submit the Journal’s copyright transfer 
agreement, which includes a section on the disclosure of potential conflicts of interest 
based on the recommendations of the International Committee of Medical Journal Editors, 
“Uniform Requirements for Manuscripts Submitted to Biomedical Journals” 
(www.icmje.org/update.html). The form is readily available on the manuscript submission 
page and can be completed and submitted electronically. Please note that authors may 
sign the copyright transfer agreement form electronically. For additional information about 
electronically signing this form, go to http://links.lww.com/ZUAT/A106.  
Permissions  
Authors must submit written permission from the copyright owner (usually the publisher) 
to use direct quotations, tables, or illustrations that have appeared in copyrighted form 
elsewhere, along with complete details about the source. Any permissions fees that might 
be required by the copyright owner are the responsibility of the authors requesting use of 
the borrowed material, not the responsibility of Lippincott Williams & Wilkins.  
Original Articles 
Articles should not exceed 2,500 words.  
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Case Reports 
All Case Reports must have a Structured Abstract and will be published online only. The 
abstract will appear in the hard copy of the Journal, and the readers will be directed to the 
Journal’s Web site to view the paper in its entirety. All papers published online only will be 
completely referenced and indexed.  
On the Other Hand 
The Journal accepts submissions for its feature column, "On the Other Hand." Submit 
ideas, hints, suggestions and tips in the form of one- to two-thought concepts, 500 - 600 
words in length, accompanied by illustrations and a bibliography when appropriate. The 
Journal also publishes reader response letters about items that have appeared in the "On 
the Other Hand" column.  
Letters to the Editor 
The Journal welcomes letters about articles that have appeared in recent issues. Letters 
are forwarded to the author of the article for reply. Upon acceptance, both letters will be 
published online only.  
MANUSCRIPT SUBMISSION On-line Manuscript Submission  
All manuscripts must be submitted on-line through http://jpo.edmgr.com/. First-time 
users: Please click the Register button from the main menu and enter the requested 
information. On successful registration, you will be sent an e-mail indicating your user 
name and password. Print a copy of this information for future reference. Note: If you 
have received an e-mail from us with an assigned user ID and password, or if you are a 
repeat user, do not register again. Just log in. Once you have an assigned ID and 
password, you do not have to re-register, even if your status changes (that is, author, 
reviewer, or editor). Authors: Please click the log-in button from the menu at the top of 
the page and log in to the system as an Author. Submit your manuscript according to the 
author instructions. You will be able to track the progress of your manuscript through the 
system. If you experience any problems, please contact the Editorial Office e-
mail:pregis@lww.com, telephone: (360) 297-8698, fax: (360) 297-8697. Requests for 
help and other questions will be addressed in the order received.  
PREPARATION OF MANUSCRIPT  
Manuscripts that do not adhere to the following instructions will be returned to the 
corresponding author for technical revision before undergoing peer review.  
Title Page 
The title page must be submitted as a separate file. Include on the title page (a) 
complete manuscript title; (b) authors' full names, highest academic degrees, and 
affiliations; (c) name and address for correspondence, including fax number, telephone 
number, and e-mail address; (d) address for reprints if different from that of 
corresponding author; and (e) all sources of support, including pharmaceutical and 
industry support, that require acknowledgment.  
 
The title page must also include disclosure of funding received for this work from any of 
the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard 
Hughes Medical Institute (HHMI); and other(s).  
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Structured Abstract and Levels of Evidence 
A structured abstract of no more than 325 words, consisting of five paragraphs, with the 
headings Background (which states the primary research question), Methods, Results, 
Conclusions, and Level of Evidence (for clinical articles) or Clinical Relevance (for basic-
science articles).Limit the use of abbreviations and acronyms. For the Level of Evidence 
section, describe the study type and assign a level-of-evidence rating to the primary 
research question, according to the criteria in the table in the Instructions to Authors.  
Levels of Evidence for Primary Research Question1 
   Types of Studies 
   
Therapeutic Studies—
Investigating the Results of 
Treatment 
Prognostic Studies—
Investigating the Effect 
of a Patient 
Characteristic on the 









Level I • High-quality randomized 
controlled trial with statistically 
significant difference or no 
statistically significant 
difference but narrow 
confidence intervals  
•  Systematic review2 of 
Level-I randomized controlled 
trials (and study results were 
homogeneous3) 
• High-quality prospective 
study4 (all patients were 
enrolled at the same point 
in their disease with ≥80% 
follow-up of enrolled 
patients)  
•  Systematic review2 of 
Level-I studies 
• Testing of previously 
developed diagnostic 
criteria in series of 
consecutive patients (with 
universally applied 
reference "gold" standard)  
•  Systematic review2 of 
Level-I studies 
• Sensible costs and 
alternatives; values 
obtained from many 
studies; multiway 
sensitivity analyses  
•  Systematic review2 
of Level-I studies 
Level II • Lesser-quality randomized 
controlled trial (e.g., <80% 
follow-up, no blinding, or 
improper randomization)  
•  Prospective4 comparative 
study5  
•  Systematic review2 of 
Level-II studies or Level-I 
studies with inconsistent 
results 
• Retrospective6 study  
•  Untreated controls from 
a randomized controlled 
trial  
•  Lesser-quality 
prospective study (e.g., 
patients enrolled at 
different points in their 
disease or <80% follow-
up)  
•  Systematic review2 of 
Level-II studies 
• Development of 
diagnostic criteria on basis 
of consecutive patients 
(with universally applied 
reference "gold" standard)  
•  Systematic review2 of 
Level-II studies 
• Sensible costs and 
alternatives; values 
obtained from limited 
studies; multiway 
sensitivity analyses  
•  Systematic review2 
of Level-II studies 
Level III • Case-control study7  
•  Retrospective6 comparative 
study5  
•  Systematic review2 of 
Level-III studies 
• Case-control study7 • Study of nonconsecutive 
patients (without 
consistently applied 
reference "gold" standard)  
•  Systematic review2 of 
Level-III studies 
• Analyses based on 
limited alternatives 
and costs; poor 
estimates  
•  Systematic review2 
of Level-III studies 
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Level IV Case series8 Case series • Case-control study  
•  Poor reference standard 
• No sensitivity 
analyses 
Level V Expert opinion Expert opinion Expert opinion Expert opinion 
1.        A complete assessment of the quality of individual studies requires critical appraisal of all aspects of the study 
design.  
2.        A combination of results from two or more prior studies.  
3.        Studies provided consistent results.  
4.        Study was started before the first patient enrolled.  
5.        Patients treated one way (e.g., with cemented hip arthroplasty) compared with patients treated another way (e.g., 
with cementless hip arthroplasty) at the same institution.  
6.        Study was started after the first patient enrolled.  
7.        Patients identified for the study on the basis of their outcome (e.g., failed total hip arthroplasty), called "cases," are 
compared with those who did not have the outcome (e.g., had a successful total hip arthroplasty), called "controls."  
8.        Patients treated one way with no comparison group of patients treated another way. 
This chart is reprinted from The Journal of Bone and Joint Surgery. 
Text 
Each manuscript page must be numbered clearly, with line numbers continuing 
throughout. Organize the manuscript into four main headings: 
Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first 
mention in text and in each table and figure. If a brand name is cited, supply the 
manufacturer's name and address (city and state/country).  
Abbreviations 
For a list of standard abbreviations, consult the Council of Biology Editors Style Guide 
(available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) 
or other standard sources. Write out the full term for each abbreviation at its first use 
unless it is a standard unit of measure.  
References 
The authors are responsible for the accuracy of the references. Key the references 
(double-spaced) at the end of the manuscript. Cite the references in text in the order of 
appearance. Cite unpublished data—such as papers submitted but not yet accepted for 
publication and personal communications, including e-mail communications—in 
parentheses in the text. If there are more than three authors, name only the first three 
authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for 
abbreviations of journal names, or access the list at 
http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:  
 
Journal article  
1. Rand NS, Dawson JM, Juliao SF, et al. In vivo macrophage recruitment by 
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murine intervertebral disc cells. J Spinal Disord. 2001;14:339-342.  
 
Book chapter  
2. Todd VR. Visual information analysis: frame of reference for visual perception. 
In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational 
Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:205-256.  
 
Entire book  
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation.Philadelphia, 
PA: Lippincott Williams & Wilkins; 1999.  
 
Software  
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease 
Control and Prevention; 1994.  
 
Online journals  
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet 
Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information 
Technologies, McLean, VA. Accessed December 15, 1990.  
 
Database  
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 
1996. Updated March 29, 1996.  
 
World Wide Web  
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. 
Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 
1997.  
Figures:  
A) Creating Digital Artwork  
1. Learn about the publication requirements for Digital Artwork: 
http://links.lww.com/ES/A42  
2. Create, Scan and Save your artwork and compare your final figure to the Digital 
Artwork Guideline Checklist (below).  
3. Upload each figure to Editorial Manager in conjunction with your manuscript text 
and tables.  
B) Digital Artwork Guideline Checklist  
Here are the basics to have in place before submitting your digital artwork:  
• Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High 
resolution PDF files are also acceptable.  
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• Crop out any white or black space surrounding the image.  
• Diagrams, drawings, graphs, and other line art must be vector or saved at a 
resolution of at least 1200 dpi. If created in an MS Office program, send the native 
(DOC, PPT, XLS) file.  
• Photographs, radiographs and other halftone images must be saved at a resolution 
of at least 300 dpi.  
• Photographs and radiographs with text must be saved as postscript or at a 
resolution of at least 600 dpi.  
• Each figure must be saved and submitted as a separate file. Figures should not be 
embedded in the manuscript text file.  
Remember:  
• Cite figures consecutively in your manuscript.  
• Number figures in the figure legend in the order in which they are discussed.  
• Upload figures consecutively to the Editorial Manager web site and enter figure 
numbers consecutively in the Description field when uploading the files.  
Figure Legends 
Include legends for all figures. They should be brief and specific, and they should appear 
on a separate manuscript page after the references. Use scale markers in the image for 
electron micrographs, and indicate the type of stain used.  
Color Figures 
The journal accepts for publication color figures that will enhance an article. Authors who 
submit color figures will receive an estimate of the cost for color reproduction. If they 
decide not to pay for color reproduction, they can request that the figures be converted to 
black and white at no charge.  
Tables 
Create tables using the table creating and editing feature of your word processing software 
(eg, Word, WordPerfect). Group all tables in a separate file. Cite tables consecutively in 
the text, and number them in that order. Each table should appear on a separate sheet 
and should include the table title, appropriate column heads, and explanatory legends 
(including definitions of any abbreviations used). Do not embed tables within the body of 
the manuscript. They should be self-explanatory and should supplement, rather than 
duplicate, the material in the text.  
Style 
Pattern manuscript style after the American Medical Association Manual of Style (9th 
edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate 
Dictionary (10th edition) should be used as standard references. Refer to drugs and 
therapeutic agents by their accepted generic or chemical names, and do not abbreviate 
them. Use code numbers only when a generic name is not yet available. In that case, 
supply the chemical name and a figure giving the chemical structure of the drug is 
required. Copyright or trade names of drugs should be capitalized and placed in 
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parentheses after the name of the drug. Names and locations (city and state in USA; city 
and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a 
manuscript are required to comply with trademark law and should be provided in 
parentheses. Units of measure should be expressed in the metric system, and 
temperatures should be expressed in degrees Celsius. Conventional units should be written 
as SI units as appropriate.  
AFTER ACCEPTANCE  
Page Proofs and Corrections  
Corresponding authors will receive electronic page proofs to check the copyedited and 
typeset article before publication. Portable document format (PDF) files of the typeset 
pages and support documents (eg, reprint order form) will be sent to the corresponding 
author by e-mail. Complete instructions will be provided with the e-mail for downloading 
and printing the files and for faxing the corrected page proofs to the publisher. Those 
authors without an e-mail address will receive traditional page proofs. It is the author's 
responsibility to ensure that there are no errors in the proofs. Changes that have been 
made to conform to journal style will stand if they do not alter the authors' meaning. Only 
the most critical changes to the accuracy of the content will be made. Changes that are 
stylistic or are a reworking of previously accepted material will be disallowed. The 
publisher reserves the right to deny any changes that do not affect the accuracy of the 
content. Authors may be charged for alterations to the proofs beyond those required to 
correct errors or to answer queries. Proofs must be checked carefully and corrections faxed 
within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page 
proofs.  
Reprints 
Authors will receive a reprint order form and a price list with the page proofs. Reprint 
requests should be faxed to the publisher with the corrected proofs, if possible. Reprints 
are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. 
Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, 
Philadelphia, PA 19106 with any questions.  
Publisher's Contact 
Fax corrected page proofs, reprint order form, and any other related materials to Journal 
Production Editor, Journal of Pediatric Orthopaedics (443) 817-0913. Color proofs should 
be returned to Journal Production Editor, Journal of Pediatric Orthopaedics, Lippincott 
Williams & Wilkins, 351 West Camden Street, Baltimore, MD 21201. 
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